depending on the stage of the disease , there were elevated levels in 11 % of operable breast cancer patients preoperatively , in 7 % of the cases with no evidence of disease after primary treatment and in 63.5 % of patients with disseminated mammary carcinoma .
C0006142
of
C0006141
mammary